Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan Therapeutics, Inc.; Encourages Investors to Contact the Firm PR...
SALISBURY, United Kingdom and PALO ALTO, Calif., June 22, 2016 (GLOBE NEWSWIRE) -- KalVista Pharmaceuticals Ltd. (“KalVista”), a privately held biopharmaceutical company, and Carbylan...
--Transaction forms combined NASDAQ-listed biopharmaceutical company, focused on the discovery, development and commercialization of plasma kallikrein inhibitors for the treatment of hereditary...
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Carbylan Therapeutics, Inc. (NASDAQGM: CBYL) violated federal securities laws in...
Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; NewLink Genetics Corporation, DeVry Education Group, Inc., Target Corporation, La Quinta Holdings Inc and...
PALO ALTO, Calif., April 15, 2016 (GLOBE NEWSWIRE) -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company, announced today that it has suspended further clinical...
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Carbylan Therapeutics, Inc. (“Carbylan” or the “Company”) (NASDAQ: CBYL) concerning the Company and...
Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; La Quinta Holdings Inc., DS Healthcare Group, Inc., LPL Financial Holdings Inc., Amaya Inc. and Carbylan...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of investors of Carbylan Therapeutics, Inc. (“Carbylan” or the “Company”) (NASDAQ: CBYL) concerning the...
Levi & Korsinsky announces it has commenced an investigation of Carbylan Therapeutics, Inc. (“Carbylan” or the “Company”) (NASDAQ:CBYL) concerning possible violations of federal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.